Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ImmunoGenesis Logo
ImmunoGenesis Growth Score
94
CB Rank
13350
Heat Score
86
ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.
Founded
obfuscation
PrivateGrant Houston, Texas, United States11-50 www.immunogenesis.com/
Biotechnology
Health Care
Health Diagnostics
Life Science
Medical
Therapeutics
Overview

ImmunoGenesis
Total Funding
obfuscation
Growth Score
94
Heat Score
86

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score94
2 pts
in past quarter
Heat Score 86
23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About ImmunoGenesis

CB Rank
13350
ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.
Founded
obfuscation
PrivateGrant Houston, Texas, United States11-50 www.immunogenesis.com/
Biotechnology
Health Care
Health Diagnostics
Life Science
Medical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name ImmunoGenesis, Inc.
Operating Status Active
Company Type For Profit
Founders  Michael Curran, William Tanner
About the Company
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.
Phone Number 346-772-0336
Contact Email info@immunogenesis.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

IMGS-001
A dual-specific PD-L1/PD-L2 inhibitor with cytotoxic effector function designed to treat immune-excluded tumors resistant to existing immunotherapies.
IMGS-501
An antibody-conjugated STING agonist that uses a PD-L1/PD-L2 dual-specific antibody to deliver the STING agonist systemically to tumor sites, overcoming limitations of traditional STING agonists.

Research & Development

ImmunoGenesis is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant
obfuscation
Grant - ImmunoGenesis Logo
Grant - ImmunoGenesis
1
obfuscation
Cancer Prevention and Research Institute of TexasGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 6

Employee Profiles

News

News and Press

News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

138
-69.13%
 in past month

IT Spend

$109.1KThis year, ImmunoGenesis is projected to spend $109.1K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Spine-Leaf Architecture Logo
Spine-Leaf Architecture
67
Buyer Needs Logo
Buyer Needs
67

Active Website Tech Count

26ImmunoGenesis is actively using 26 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

16The intellectual property of ImmunoGenesis includes 15 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, ImmunoGenesis has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ImmunoGenesis's headquarters? ImmunoGenesis is located in Houston, Texas, United States.Who invested in ImmunoGenesis? ImmunoGenesis has 4 investors including Cancer Prevention and Research Institute of Texas and  Cancer Focus Fund.When was the last funding round for ImmunoGenesis? ImmunoGenesis closed its last funding round on
obfuscation
from a Grant round.Who are ImmunoGenesis's competitors? Alternatives and possible competitors to ImmunoGenesis may include Roche, AstraZeneca, and  Regeneron.How much funding has ImmunoGenesis raised to date? ImmunoGenesis has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d46e5f 1)
|